SG Americas Securities
FRLN

SG Americas Securities’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

SG Americas Securities’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,444
Closed -$45K – 3656
2022
Q2 		$45K Sell
3,444
-513
-13% -$6.6K ﹤0.01% 3278
2022
Q1 		$66K Buy
3,957
+319
+9% +$5.92K ﹤0.01% 2819
2021
Q4 		$108K Buy
3,638
+479
+15% +$19.6K ﹤0.01% 3051
2021
Q3 		$163K Buy
+3,159
New +$225K ﹤0.01% 3367

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SG Americas Securities's FRLN Position: Q3 2022 in Review

SG Americas Securities sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2022, closing a stake of 3,444 shares — an estimated $45K sold.

SG Americas Securities first reported a position in FRLN in Q3 2021 and held it in 4 quarters. The position peaked at $163K in Q3 2021. 14 funds tracked by Wall St. Rank hold FRLN as of Q3 2022.

  • SG Americas Securities reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 3,444 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2022, an estimated $45K.
  • SG Americas Securities first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 4 quarters.
  • SG Americas Securities's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $163K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.